Changes in survivin messenger RNA level during chemotherapy treatment in ovarian cancer cells

Cancer Biol Ther. 2005 Jul;4(7):716-9. doi: 10.4161/cbt.4.7.1782. Epub 2005 Jul 2.

Abstract

Objective: To investigate the role of antiapoptosis gene, survivin involved in regulating cell sensitivity to taxanes and platinum compounds.

Methods: Cultured human epithelial ovarian cancer cell line A2780 and its platinum(DDP)-resistance cell line A2780/DDP were divided into three groups as control, treatment with DDP, and treatment with Taxol Expression of mdr1 and survivin genes in each group was detected by using reverse transcription-polymerase chain reaction (RT-PCR). Apoptosis in the ovarian cancer cell lines was measured by flow cytometry.

Results: After treatment with DDP for 48 h, relative survivin expression was significantly lower than that of no drug given (p<0.05). In A2780/DDP cells, expression of Survivn was obviously higher than that of the control group (P<0.05) after treatment of DDP for 48 h. Interestingly, survivin mRNA level was significantly decreased after treatment with Taxol for 48 h in the A2780/DDP-Taxol group compared with that in the control group. Apoptosis rate of A2780 cells was significantly increased to 46.21% and 44.46%, respectively, with treatment of DDP and Taxol. However, apoptosis rate in A2780/DDP was only 20.04% after DDP treatment for 48 h, demonstrating the presence of resistance to DDP in A2780/DDP cells.

Conclusions: This study demonstrated that changes in survivin mRNA level were related to the chemotherapy-induced apoptosis. Survivin may be considered as a biological indicator of the chemo-resistance of ovarian cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / genetics
  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / metabolism
  • Antineoplastic Agents / pharmacology
  • Apoptosis / drug effects
  • Cisplatin / pharmacology
  • Drug Resistance, Neoplasm*
  • Female
  • Flow Cytometry
  • Humans
  • Inhibitor of Apoptosis Proteins
  • Microtubule-Associated Proteins / genetics*
  • Microtubule-Associated Proteins / metabolism
  • Neoplasm Proteins / genetics*
  • Neoplasm Proteins / metabolism
  • Ovarian Neoplasms / drug therapy*
  • Ovarian Neoplasms / genetics
  • Ovarian Neoplasms / metabolism*
  • Paclitaxel / pharmacology
  • RNA, Messenger / metabolism*
  • Reverse Transcriptase Polymerase Chain Reaction
  • Survivin
  • Tumor Cells, Cultured

Substances

  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Antineoplastic Agents
  • BIRC5 protein, human
  • Inhibitor of Apoptosis Proteins
  • Microtubule-Associated Proteins
  • Neoplasm Proteins
  • RNA, Messenger
  • Survivin
  • Paclitaxel
  • Cisplatin